The "Fourth Terminal" exploded!

Medical Network, June 16 News On June 15, the pharmaceutical Internet platform "Pharmacist Gang" announced the completion of a new round of financing of 270 million US dollars.
Participating in this round of financing are Zhujiang Investment, Baidu, Sunshine Insurance, Songhe Capital, Guangzhou Fund and A country’s sovereign fund
.
Coincidentally, on June 8, the pharmaceutical e-commerce company "Dingdang Kuaiyao" received a strategic investment, led by Aobo Capital, Hongwei Capital, and TPG Asia Fund, with a financing amount of US$220 million
.

 

Pharmacist Gang and Dingdang Kuaiyao's high-dollar financing has aroused heated discussions inside and outside the industry, and it also shows that the capital market is paying more and more attention to the "fourth terminal" model of online drug purchase outside hospitals
.

 

Obtained the attention and recognition of the capital market

 

It is understood that Pharmacist helped to obtain a new round of US$270 million in financing to continue to empower the upgrade of the pharmaceutical industry chain
.
On the basis of the completed user scale and online transaction scale, the funds obtained by the pharmacist in this round of financing will be mainly used for the technical upgrade of the whole process of the contract, and continue to improve the user experience; the iteration and iteration of the digital marketing system of the pharmaceutical company’s off-hospital market Construction, as well as the construction of a data sharing platform for professional service scenarios in pharmacies and clinics
.

 

Founded in 2015, Pharmacist Gang is a comprehensive service platform focusing on the intelligent supply chain of medicine , dedicated to solving the pain points of daily business of pharmaceutical companies such as drug inquiry, drug purchase, and drug use
.
In 2018, led by giants such as Tencent and Alibaba, B2B trading platform financing events reached 184 times
.
In the same year, Pharmacist Gang also developed rapidly, becoming the No.
1 pharmaceutical B2B platform in China with the largest number of active users
.
Since the second half of 2020, its pharmaceutical B2B trading platform has introduced 1,000+ exclusive varieties directly supplied by pharmaceutical companies
.
As of December 2020, the pharmacist’s help covers 350,000+ purchase terminals, and the monthly active ratio is as high as 70%
.

 

In addition to the US$270 million in financing this time, Pharmacist Gang has completed 6 rounds of financing
.
In December 2018, the Pharmacist Group announced the completion of USD 133 million in Series D financing, with participation from Tiger Global Fund, H Capital and DCM; in June 2018, the Pharmacist Group announced the completion of a series of financing of RMB 420 million in Series C, of ​​which the C1 round was funded by Shunwei Capital led the investment, Songhe Capital and Gaojie Capital participated in the investment, the C2 round was led by DCM Capital, and SIG followed the investment; at the end of 2016, the Pharmacist Group announced the completion of 110 million yuan in round B financing, led by Songhe and Fosun; 2016 A round of 71 million yuan financing was completed in April 2015; in May 2015, the pharmacist helped to complete a Pre-A round of 10 million yuan financing
.

 

Also recognized by the capital market is Dingdang Kuaiyao, a medical e-commerce company known as "takeaway"
.
Public information shows that Dingdong Kuaiyao is an O2O-based medical and health Internet product, founded in September 2014 by Yang Wenlong, chairman of Renhe Group
.
In the 7 years since its establishment, Dingdang Kuaiyao has obtained 7 rounds of financing, with a cumulative financing amount of more than 3 billion yuan.
The main investment institutions include Tongdao Capital, Softbank China, Taikang Life Insurance, and TPG Asia Fund
.

 

Regarding the US$220 million financing, Yang Wenlong, the founder and chairman of Dingdang Kuaiyao, said: "With this round of financing, Dingdang Kuaiyao will promote the implementation of the'medicine + medicine + insurance' strategy of reaching home for health
.
" In terms of O2O service, Dingdang Kuaiyao has a clear advantage in delivery speed compared to platforms such as Alibaba Health
.
According to official data, Dingdang Kuaiyao currently covers 10 major cities, with over 300 self-operated pharmacies and a service area of ​​more than 6,000 square kilometers
.
From the perspective of delivery time, the industry’s average delivery time is about 50 minutes, and Dingdang’s average delivery time is 24.
85 minutes, pushing "fast" to the extreme
.

 

In the “online medical + medical e-commerce + health insurance” field layout, Alibaba Health and JD Health have obvious advantages in technology and traffic, but they are not as fast as Dingdang fast medicine in terms of rapid delivery of medicines; Ping An Health’s advantage lies in insurance and lacks e-commerce genes ; Dingdang Express has the advantage of delivering drugs in the core area within 28 minutes, but self-operated pharmacies and distribution bring huge costs
.
In this sense, although it has just received 220 million US dollars in financing, Dingdang Kuaiyao still needs to continue to consolidate its own advantages in order to gain a firm foothold in the field of Internet health
.

 

　　The industry generally believes that the frequent financing of pharmaceutical e-commerce is largely due to the fact that the capital market is optimistic about the future development trend of the out-of-hospital market
.

 

　　 "Fourth Terminal" enters the fast lane of development

 

　　Since 2020, the impact of the epidemic has been superimposed, the separation of medicines, the outflow of prescriptions from hospitals have significantly accelerated, and the out-of-hospital market of prescription drugs has continued to expand
.
The epidemic has given pharmaceutical e-commerce and Internet medical services a real "trial", and they are becoming an important part of China's pharmaceutical distribution and medical service system.
The rapidly growing pharmaceutical e-commerce has been urged by the epidemic to become the "fourth terminal".
Continue to be favored
.

 

　　According to data from Mi Nei.
com, drug sales in China's three major terminals and six major markets will reach 1,643.
7 billion yuan in 2020, a year-on-year negative growth of 8.
5%
.
Retail pharmacy terminals were the least affected by the epidemic among the three terminals and recovered quickly
.
Data show that the retail pharmacy terminal market will reach 433 billion yuan in sales in 2020, a year-on-year increase of 3.
2%
.
The retail pharmacy terminal includes two major markets, physical pharmacies and online pharmacies
.
Among them, the sales of online pharmacies reached 24.
3 billion yuan in 2020, a year-on-year increase of 75.
6%
.

 

　　In the past two years, the “Fourth Terminal”, an online platform outside the hospital, has developed vigorously, which is inseparable from the support of the pharmaceutical market to the outside market
.
From the perspective of industry insiders, Internet sales of prescription drugs have clearer support at the policy level, which allows capital to see new directions and hopes
.
However, Internet medical care, which has entered the "burst harvest period" due to the impact of the new crown epidemic, has once again ushered in further loosening and tilting of the policy side
.

 

　　Since 2020, due to the needs of epidemic prevention and control, the National Health Commission, the National Medical Insurance Administration and other departments have intensively introduced a series of policies to vigorously promote the development of Internet hospitals
.
For example, the "Guiding Opinions on Actively Promoting "Internet +" Medical Services and Medical Insurance Payments" issued by the National Medical Insurance Bureau supports the development of "Internet +" medical services that meet the requirements and implements fair medical insurance payments for online and offline medical services.
Policy
.
The promulgation of the guidance will not only promote the development of Internet healthcare, but will also continue to strengthen the monetization capabilities of Internet platform companies
.

 

　　The General Office of the State Council issued on April 15 the "Opinions on Serving the "Six Stability" and "Six Guarantees" to further improve the work related to the reform of "delegation, management and service", which stated that "On the premise of ensuring the authenticity of electronic prescription sources, Online sales of prescription drugs other than those under special state management are allowed
.
"

 

　　A week before the publication of the above-mentioned documents, Hainan has introduced a new policy
.
On April 8, the National Development and Reform Commission and the Ministry of Commerce issued the "Opinions on Several Special Measures to Support the Construction of Hainan Free Trade Port to Relax Market Access", which mentioned that Hainan will be used as a national pilot for market access liberalization and 22 special measures have been introduced.
This includes supporting Hainan to carry out Internet prescription drug sales, allowing the establishment of Hainan's electronic prescription center, and being the country's first independently operated electronic prescription center.
This move is also considered a breakthrough in Internet prescription drug sales
.

 

　　With favorable policies and the expansion of market size, pharmaceutical e-commerce companies continue to be favored by capital
.
Although the broad market prospects of pharmaceutical e-commerce have attracted many participants, some senior industry experts believe that pharmaceutical e-commerce only solves the convenience of selling drugs and does not provide professional medication guidance capabilities, especially in the field of prescription drugs.
It is the direction that it needs to continue to build and conquer in the future
.

　　Medical Network, June 16 News On June 15, the pharmaceutical Internet platform "Pharmacist Gang" announced the completion of a new round of financing of 270 million US dollars.
Participating in this round of financing are Zhujiang Investment, Baidu, Sunshine Insurance, Songhe Capital, Guangzhou Fund and A country’s sovereign fund
.
Coincidentally, on June 8, the pharmaceutical e-commerce company "Dingdang Kuaiyao" received a strategic investment, led by Aobo Capital, Hongwei Capital, and TPG Asia Fund, with a financing amount of US$220 million
.

 

　　Pharmacist Gang and Dingdang Kuaiyao's high-dollar financing has aroused heated discussions inside and outside the industry, and it also shows that the capital market is paying more and more attention to the "fourth terminal" model of online drug purchase outside hospitals
.

 

　　Obtained the attention and recognition of the capital market

 

　　It is understood that Pharmacist helped to obtain a new round of US$270 million in financing to continue to empower the upgrade of the pharmaceutical industry chain
.
On the basis of the completed user scale and online transaction scale, the funds obtained by the pharmacist in this round of financing will be mainly used for the technical upgrade of the whole process of the contract, and continue to improve the user experience; the iteration and iteration of the digital marketing system of the pharmaceutical company’s off-hospital market Construction, as well as the construction of a data sharing platform for professional service scenarios in pharmacies and clinics
.

 

　　Founded in 2015, Pharmacist Gang is a comprehensive service platform focusing on the intelligent supply chain of medicine , dedicated to solving the pain points of daily business of pharmaceutical companies such as drug inquiry, drug purchase, and drug use
.
In 2018, led by giants such as Tencent and Alibaba, B2B trading platform financing events reached 184 times
.
In the same year, Pharmacist Gang also developed rapidly, becoming the No.
1 pharmaceutical B2B platform in China with the largest number of active users
.
Since the second half of 2020, its pharmaceutical B2B trading platform has introduced 1,000+ exclusive varieties directly supplied by pharmaceutical companies
.
As of December 2020, the pharmacist’s help covers 350,000+ purchase terminals, and the monthly active ratio is as high as 70%
.

 

　　In addition to the US$270 million in financing this time, Pharmacist Gang has completed 6 rounds of financing
.
In December 2018, the Pharmacist Group announced the completion of USD 133 million in Series D financing, with participation from Tiger Global Fund, H Capital and DCM; in June 2018, the Pharmacist Group announced the completion of a series of financing of RMB 420 million in Series C, of ​​which the C1 round was funded by Shunwei Capital led the investment, Songhe Capital and Gaojie Capital participated in the investment, the C2 round was led by DCM Capital, and SIG followed the investment; at the end of 2016, the Pharmacist Group announced the completion of 110 million yuan in round B financing, led by Songhe and Fosun; 2016 A round of 71 million yuan financing was completed in April 2015; in May 2015, the pharmacist helped to complete a Pre-A round of 10 million yuan financing
.

 

　　Also recognized by the capital market is Dingdang Kuaiyao, a medical e-commerce company known as "takeaway"
.
Public information shows that Dingdong Kuaiyao is an O2O-based medical and health Internet product, founded in September 2014 by Yang Wenlong, chairman of Renhe Group
.
In the 7 years since its establishment, Dingdang Kuaiyao has obtained 7 rounds of financing, with a cumulative financing amount of more than 3 billion yuan.
The main investment institutions include Tongdao Capital, Softbank China, Taikang Life Insurance, and TPG Asia Fund
.

 

　　Regarding the US$220 million financing, Yang Wenlong, the founder and chairman of Dingdang Kuaiyao, said: "With this round of financing, Dingdang Kuaiyao will promote the implementation of the'medicine + medicine + insurance' strategy of reaching home for health
.
" In terms of O2O service, Dingdang Kuaiyao has a clear advantage in delivery speed compared to platforms such as Alibaba Health
.
According to official data, Dingdang Kuaiyao currently covers 10 major cities, with over 300 self-operated pharmacies and a service area of ​​more than 6,000 square kilometers
.
From the perspective of delivery time, the industry’s average delivery time is about 50 minutes, and Dingdang’s average delivery time is 24.
85 minutes, pushing "fast" to the extreme
.

 

　　In the “online medical + medical e-commerce + health insurance” field layout, Alibaba Health and JD Health have obvious advantages in technology and traffic, but they are not as fast as Dingdang fast medicine in terms of rapid delivery of medicines; Ping An Health’s advantage lies in insurance and lacks e-commerce genes ; Dingdang Express has the advantage of delivering drugs in the core area within 28 minutes, but self-operated pharmacies and distribution bring huge costs
.
In this sense, although it has just received 220 million US dollars in financing, Dingdang Kuaiyao still needs to continue to consolidate its own advantages in order to gain a firm foothold in the field of Internet health
.

 

　　The industry generally believes that the frequent financing of pharmaceutical e-commerce is largely due to the fact that the capital market is optimistic about the future development trend of the out-of-hospital market
.

 

　　 "Fourth Terminal" enters the fast lane of development

 

　　Since 2020, the impact of the epidemic has been superimposed, the separation of medicines, the outflow of prescriptions from hospitals have significantly accelerated, and the out-of-hospital market of prescription drugs has continued to expand
.
The epidemic has given pharmaceutical e-commerce and Internet medical services a real "trial", and they are becoming an important part of China's pharmaceutical distribution and medical service system.
The rapidly growing pharmaceutical e-commerce has been urged by the epidemic to become the "fourth terminal".
Continue to be favored
.

 

　　According to data from Mi Nei.
com, drug sales in China's three major terminals and six major markets will reach 1,643.
7 billion yuan in 2020, a year-on-year negative growth of 8.
5%
.
Retail pharmacy terminals were the least affected by the epidemic among the three terminals and recovered quickly
.
Data show that the retail pharmacy terminal market will reach 433 billion yuan in sales in 2020, a year-on-year increase of 3.
2%
.
The retail pharmacy terminal includes two major markets, physical pharmacies and online pharmacies
.
Among them, the sales of online pharmacies reached 24.
3 billion yuan in 2020, a year-on-year increase of 75.
6%
.

 

　　In the past two years, the “Fourth Terminal”, an online platform outside the hospital, has developed vigorously, which is inseparable from the support of the pharmaceutical market to the outside market
.
From the perspective of industry insiders, Internet sales of prescription drugs have clearer support at the policy level, which allows capital to see new directions and hopes
.
However, Internet medical care, which has entered the "burst harvest period" due to the impact of the new crown epidemic, has once again ushered in further loosening and tilting of the policy side
.

 

　　Since 2020, due to the needs of epidemic prevention and control, the National Health Commission, the National Medical Insurance Administration and other departments have intensively introduced a series of policies to vigorously promote the development of Internet hospitals
.
For example, the "Guiding Opinions on Actively Promoting "Internet +" Medical Services and Medical Insurance Payments" issued by the National Medical Insurance Bureau supports the development of "Internet +" medical services that meet the requirements and implements fair medical insurance payments for online and offline medical services.
Policy
.
The promulgation of the guidance will not only promote the development of Internet healthcare, but will also continue to strengthen the monetization capabilities of Internet platform companies
.

 

　　The General Office of the State Council issued on April 15 the "Opinions on Serving the "Six Stability" and "Six Guarantees" to further improve the work related to the reform of "delegation, management and service", which stated that "On the premise of ensuring the authenticity of electronic prescription sources, Online sales of prescription drugs other than those under special state management are allowed
.
"

 

　　A week before the publication of the above-mentioned documents, Hainan has introduced a new policy
.
On April 8, the National Development and Reform Commission and the Ministry of Commerce issued the "Opinions on Several Special Measures to Support the Construction of Hainan Free Trade Port to Relax Market Access", which mentioned that Hainan will be used as a national pilot for market access liberalization and 22 special measures have been introduced.
This includes supporting Hainan to carry out Internet prescription drug sales, allowing the establishment of Hainan's electronic prescription center, and being the country's first independently operated electronic prescription center.
This move is also considered a breakthrough in Internet prescription drug sales
.

 

　　With favorable policies and the expansion of market size, pharmaceutical e-commerce companies continue to be favored by capital
.
Although the broad market prospects of pharmaceutical e-commerce have attracted many participants, some senior industry experts believe that pharmaceutical e-commerce only solves the convenience of selling drugs and does not provide professional medication guidance capabilities, especially in the field of prescription drugs.
It is the direction that it needs to continue to build and conquer in the future
.